News | Ablation Systems | May 04, 2018

Stereotaxis and Acutus Medical Announce Strategic Collaboration

Integration of Stereotaxis’ Niobe magnetic navigation system and Acutus Medical’s AcQMap high-res imaging and mapping system will improve workflow during ablation procedures

 

Stereotaxis and Acutus Medical Announce Strategic Collaboration

May 4, 2018 — Stereotaxis and Acutus Medical announced a strategic collaboration to integrate the Stereotaxis Niobe Magnetic Navigation System and the Acutus Medical AcQMap High Resolution Imaging and Mapping System. The goal of the collaboration is to improve patient care and the physician experience in electrophysiology.

“I was very excited to perform the first procedures using these two technologies together. The combination offers a dipole density map which identifies higher resolution conduction patterns and a therapy strategy utilizing robotic magnetic navigation to precisely steer the ablation catheter to safely apply therapy,” said Tamas Szili-Torok, M.D., Ph.D., of Erasmus Medical Center in Rotterdam, the Netherlands. “The procedures went very well, with successful treatment of patients with paroxysmal and persistent atrial fibrillation in a safe and efficient fashion. The promise of robust software integration to further enhance workflow and improve automated navigation is exciting.”

The companies have successfully performed extensive testing to demonstrate that the technologies can be used together. As part of the strategic alliance, they intend to integrate the technologies to further improve workflow and enhance the ability to provide automated navigation to areas of interest identified by the Acutus mapping system. The AcQMap System combines ultrasound anatomy reconstruction with an ability to detect and display higher resolution charge source maps of the heart. The maps can be used to identify sites of interest in complex arrhythmias that can be targeted for ablation.

The Stereotaxis Robotic Magnetic Navigation System utilizes computer-controlled magnetic fields to precisely direct and steer a cardiac ablation catheter with a magnet at its tip. Magnetically controlling the working tip of the interventional device enables physicians to navigate with precision to identified sites of interest to apply ablation therapy, even in complicated anatomy or difficult-to-reach areas of the heart.

For more information: www.acutusmedical.com, www.stereotaxis.com

 

Related Content

Noninvasive Radioablation Offers Long-term Benefits to High-risk Heart Arrhythmia Patients
News | Ablation Systems | September 17, 2019
September 17, 2019 — Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically
Biosense Webster Announces Initial Results From First-in-Human QDOT-FAST Study
News | Ablation Systems | May 16, 2019
Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc.’s QDot Micro catheter...
CardioFocus Announces Results From HeartLight X3 Ablation System Pivotal Study
News | Ablation Systems | May 16, 2019
CardioFocus Inc. announced the presentation of results from its pivotal confirmatory study evaluating the HeartLight X3...
New Global Consensus Statement Addresses Catheter Ablation of Ventricular Arrhythmias
News | Ablation Systems | May 14, 2019
The Heart Rhythm Society (HRS) in partnership with three other professional societies issued an international consensus...
Netherlands Hospital to Install State-of-the-Art MRI Ablation Center
News | Ablation Systems | May 13, 2019
Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Ablation Systems | May 10, 2019 | Dave Fornell, Editor
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve
Ablation Reduces Risk of Dementia in Patients With AFib and Carotid Artery Disease
News | Ablation Systems | May 08, 2019
Even though many medical practitioners may opt not to perform procedures on higher-risk patients, new research finds it...
CardioFocus Announces European CE Mark Approval Of HeartLight X3 System
News | Ablation Systems | April 16, 2019
CardioFocus Inc. announced the European CE Mark approval of the HeartLight X3 Endoscopic Ablation System.
First Patient Treated With QDot Micro Ablation Catheter
News | Ablation Systems | February 04, 2019
Biosense Webster has enrolled and treated the first patient in its U.S. Investigational Device Exemption (IDE) study...
Overlay Init